2seventy bio Inc (TSVT)
4.959
+0.01
(+0.18%)
USD |
NASDAQ |
May 07, 16:00
4.80
-0.16
(-3.20%)
Pre-Market: 09:20
2seventy bio Total Assets (Quarterly): 565.43M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 565.43M |
| September 30, 2023 | 640.81M |
| June 30, 2023 | 705.71M |
| March 31, 2023 | 742.44M |
| December 31, 2022 | 656.66M |
| September 30, 2022 | 708.74M |
| Date | Value |
|---|---|
| June 30, 2022 | 787.41M |
| March 31, 2022 | 851.92M |
| December 31, 2021 | 759.68M |
| September 30, 2021 | 192.96M |
| June 30, 2021 | 303.74M |
| December 31, 2020 | 312.62M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
192.96M
Minimum
Sep 2021
851.92M
Maximum
Mar 2022
602.34M
Average
681.19M
Median
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 99.03B |
| Johnson & Johnson | 171.97B |
| Macrogenics Inc | 298.42M |
| Akebia Therapeutics Inc | 241.70M |
| Tango Therapeutics Inc | 402.57M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 310.13M |
| Shareholders Equity (Quarterly) | 255.30M |
| Current Ratio | 3.977 |